Late effects of early growth hormone treatment in Down syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 5, 2010, Pages 763-769

  Myrelid, A ^a   Bergman, S ^b   Elfvik Stromberg M ^b   Jonsson, B ^a   Nyberg, F ^a   Gustafsson, J ^a   Anneren G ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Smittskyddsenheten   (Sweden)

Author keywords

Cognitive function; Down syndrome; Growth hormone; Motor function statural growth

Indexed keywords

GROWTH HORMONE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ANTHROPOMETRY; ARTICLE; BRUININKS OSERETSKY TEST OF MOTOR PROFICIENCY SECOND EDITION; CHILD; CHILD GROWTH; COGNITION; CONTROLLED STUDY; DOWN SYNDROME; EARLY INTERVENTION; FEMALE; FOLLOW UP; GROWTH CURVE; HEAD CIRCUMFERENCE; HUMAN; LEITER INTERNATIONAL PERFORMANCE SCALE REVISED; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RATING SCALE; SCHOOL CHILD; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; COGNITION; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; GROWTH; HEAD; HUMAN GROWTH HORMONE; HUMANS; INTELLIGENCE TESTS; MALE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950231823     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01679.x     Document Type: Article

References (39)

1. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 2004 5 : 725 738.
2. Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988 81 : 102 110.
3. Carr J. Six weeks to twenty-one years old: a longitudinal study of children with Down's syndrome and their families. Third Jack Tizard memorial lecture. J Child Psychol Psychiatry 1988 29 : 407 431.
4. Annerén G, Sara VR, Hall K, Tuvemo T. Growth and somatomedin responses to growth hormone in Down's syndrome. Arch Dis Child 1986 61 : 48 52.
5. Castells S, Beaulieu I, Torrado C, Wisniewski KE, Zarny S, Gelato MC. Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation. J Intellect Disabil Res 1996 40 : 509 517.
6. Ragusa L, Valetto MR, Proto C, Alberti A, Romano C, Rossodivita A, et al. IGF-I levels in prepubertal and pubertal children with Down syndrome. Minerva Endocrinol 1998 23 : 31 6.
7. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 2000 21 : 330 348.
8. Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, et al. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 1998 87 : 28 31.
9. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 2007 143 : 443 448.
10. Annerén G, Tuvemo T, Carlsson-Skwirut C, Lönnerholm T, Bang P, Sara VR, et al. Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch Dis Child 1999 80 : 334 338.
11. Arnell H, Gustafsson J, Ivarsson SA, Annerén G. Growth and pubertal development in Down syndrome. Acta Paediatr 1996 85 : 1102 1106.
12. Roid GM, Miller LJ. Leiter International Performance Scale - Revised: examiners Manual. Wood dale, IL: Stoelting Co, 1997.
13. Wechsler D. Wechsler intelligence scale for children, 3rd ed. San Antonio, TX : Psychological Corporation, 1991.
14. Bruininks R, Bruininks B. Bruininks-Oseretsky test of motor proficiency, 2nd ed. Minneapolis, MA : NCS Pearson, 2005.
15. Bruininks R. Bruininks-Oseretsky test of motor proficiency: examiner's manual. Circle Pines, MN, American Guidance Service : 1978.
16. Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, et al. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord 2009 1 : 33 45.
17. Yoon DY, Scott K, Hill MN, Levitt NS, Lambert EV. Review of three tests of motor proficiency in children. Percept Mot Skills 2006 102 : 543 551.
18. Myrelid A, Gustafsson J, Ollars B, Annerén G. Growth charts for Down's syndrome from birth to 18 years of age. Arch Dis Child 2002 87 : 97 103.
19. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000 47 : 316 323.
20. Fredriks AM, van Buuren S, van Heel WJ, Dijkman-Neerincx RH, Verloove-Vanhorick SP, Wit JM. Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child 2005 90 : 807 812.
21. Gerver WJ, de Bruin R. Body composition in children based on anthropometric data. A presentation of normal values. Eur J Pediatr 1996 155 : 870 876.
22. Torrado C, Bastian W, Wisniewski KE, Castells S. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J Pediatr 1991 119 : 478 483.
23. Rovet J, Holland J. Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group. Horm Res 1993 39 : 60 4.
24. Smith MO, Shaywitz SE, Shaywitz BA, Gertner JM, Raskin LA, Gelwan EM. Exogenous growth hormone levels predict attentional performance: a preliminary report. J Dev Behav Pediatr 1985 6 : 273 278.
25. Hokken-Koelega A, van Pareren Y, Arends N. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age. Horm Res 2005 64 : 95 9.
26. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 2006 83 : 12 9.
27. Arends NJ, Boonstra VH, Hokken-Koelega AC. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age. Pediatrics 2004 114 : 683 690.
28. Groden G. Relationships between intelligence, simple, and complex motor proficiency. Am J Ment Defic 1969 74 : 373 375.
29. Spano M, Mercuri E, Rando T, Panto T, Gagliano A, Henderson S, et al. Motor and perceptual-motor competence in children with Down syndrome: variation in performance with age. Eur J Paediatr Neurol 1999 3 : 7 13.
30. Palisano RJ, Walter SD, Russell DJ, Rosenbaum PL, Gémus M, Galuppi BE, et al. Gross motor function of children with Down syndrome: creation of motor growth curves. Arch Phys Med Rehabil 2001 82 : 494 500.
31. Connolly BH, Morgan SB, Russell FF, Fulliton WL. A longitudinal study of children with Down syndrome who experienced early intervention programming. Phys Ther 1993 73 : 170 179.
32. Moldrich RX, Dauphinot L, Laffaire J, Rossier J, Potier MC. Down syndrome gene dosage imbalance on cerebellum development. Prog Neurobiol 2007 82 : 87 94.
33. Reeves SL, Varakamin C, Henry CJ. The relationship between arm-span measurement and height with special reference to gender and ethnicity. Eur J Clin Nutr 1996 50 : 398 400.
34. Blethen SL. Leukemia in children treated with growth hormone. Trends Endocrinol Metab 1998 9 : 367 370.
35. Gamis AS. Acute myeloid leukemia and Down syndrome evolution of modern therapy - state of the art. Pediatr Blood Cancer 2005 44 : 13 20.
36. Buxhoeveden D, Fobbs A, Roy E, Casanova M. Quantitative comparison of radial cell columns in children with Down's syndrome and controls. J Intellect Disabil Res 2002 46 : 76 81.
37. Guidi S, Bonasoni P, Ceccarelli C, Santini D, Gualtieri F, Ciani E. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 2008 18 : 180 197.
38. Chakrabarti L, Galdzicki Z, Haydar TF. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 2007 27 : 11483 11495.
39. van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 2005 90 : 3304 3311.